Dysregulated noradrenergic response is associated with symptom severity in individuals with schizophrenia
Frontiers in Psychiatry · 07.11.2023 · 14
DOI: 10.3389/fpsyt.2023.1190329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 07.11.2023. Verfasst von Ana Pelegrino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS.
Abstract (Originalsprache)
Introduction
The locus coeruleus-noradrenaline (LC-NA) system is involved in a wide range of cognitive functions and may be altered in schizophrenia. A non-invasive method to indirectly measure LC activity is task-evoked pupillary response. Individuals with schizophrenia present reduced pupil dilation compared to healthy subjects, particularly when task demand increases. However, the extent to which alteration in LC activity contributes to schizophrenia symptomatology remains largely unexplored. We aimed to investigate the association between symptomatology, cognition, and noradrenergic response in individuals with schizophrenia.
Methods
We assessed task-evoked pupil dilation during a pro- and antisaccade task in 23 individuals with schizophrenia and 28 healthy subjects.
Results
Both groups showed similar preparatory pupil dilation during prosaccade trials, but individuals with schizophrenia showed significantly lower pupil dilation compared to healthy subjects in antisaccade trials. Importantly, reduced preparatory pupil dilation for antisaccade trials was associated with worse general symptomatology in individuals with schizophrenia.
Discussion
Our findings suggest that changes in LC-NA activity – measured by task-evoked pupil dilation – when task demand increases is associated with schizophrenia symptoms. Interventions targeting the modulation of noradrenergic responses may be suitable candidates to reduce schizophrenia symptomatology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto de Psiquiatria, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
- Université Paris Cité, Institut de Psychiatrie et Neurosciences de Paris, Inserm, Paris, France.
Förderung
- FIC NIH HHS
Zitieren
APA
Pelegrino, A., Guimaraes, A. L., Sena, W., Emele, N., Scoriels, L., & Panizzutti, R. (2023). Dysregulated noradrenergic response is associated with symptom severity in individuals with schizophrenia. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1190329
Vancouver
Pelegrino A, Guimaraes AL, Sena W, Emele N, Scoriels L, Panizzutti R. Dysregulated noradrenergic response is associated with symptom severity in individuals with schizophrenia. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1190329
BibTeX
@article{Pelegrino2023,
author = {Pelegrino, Ana and Guimaraes, Anna Luiza and Sena, Walter and Emele, Nwabunwanne and Scoriels, Linda and Panizzutti, Rogerio},
title = {Dysregulated noradrenergic response is associated with symptom severity in individuals with schizophrenia},
journal = {Frontiers in Psychiatry},
year = {2023},
volume = {14},
doi = {10.3389/fpsyt.2023.1190329}
}
EUVIMED